Literature DB >> 11589430

Aggressive phenotypic and genotypic features in pediatric and NF2-associated meningiomas: a clinicopathologic study of 53 cases.

A Perry1, C Giannini, R Raghavan, B W Scheithauer, R Banerjee, L Margraf, D C Bowers, R A Lytle, I F Newsham, D H Gutmann.   

Abstract

Pediatric and NF2-associated meningiomas are uncommon and poorly characterized in comparison to sporadic adult cases. In order to elucidate their molecular features, we analyzed MIB-1, progesterone receptor (PR), NF2, merlin, DAL-1, DAL-1 protein, and chromosomal arms 1p and 14q in 53 meningiomas from 40 pediatric/NF2 patients using immunohistochemistry and dual-color fluorescence in situ hybridization (FISH). Fourteen pediatric (42%) patients, including 5 previously undiagnosed patients, had NF2. The remaining 19 (58%) did not qualify. All 7 of the adult patients had NF2. Meningioma grading revealed 21 benign (40%), 26 atypical (49%), and 6 anaplastic (11%) examples. Other aggressive findings included high mitotic index (32%), high MIB-1 LI (37%), aggressive variant histology (e.g. papillary, clear cell) (25%), brain invasion (17%), recurrence (39%), and patient death (17%). FISH analysis demonstrated deletions of NF2 in 82%, DAL-1 in 82%, 1p in 60%, and 14q in 66%. NF2-associated meningiomas did not differ from sporadic pediatric tumors except for a higher frequency of merlin loss in the former (p = 0.020) and a higher frequency of brain invasion in the latter (p = 0.007). Thus, although pediatric and NF2-associated meningiomas share the common molecular alterations of their adult, sporadic counterparts, a higher fraction are genotypically and phenotypically aggressive. Given the high frequency of undiagnosed NF2 in the pediatric cases, a careful search for other features of this disease is warranted in any child presenting with a meningioma.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11589430     DOI: 10.1093/jnen/60.10.994

Source DB:  PubMed          Journal:  J Neuropathol Exp Neurol        ISSN: 0022-3069            Impact factor:   3.685


  39 in total

Review 1.  Pediatric meningiomas: a single-center experience with 15 consecutive cases and review of the literature.

Authors:  Marcelo Volpon Santos; Luciano Furlanetti; Elvis Terci Valera; Maria Sol Brassesco; Luiz Gonzaga Tone; Ricardo Santos de Oliveira
Journal:  Childs Nerv Syst       Date:  2012-06-06       Impact factor: 1.475

2.  Meningioma: a clinicopathological evaluation.

Authors:  Nasrin Samadi; Seyed Ali Ahmadi
Journal:  Malays J Med Sci       Date:  2007-01

Review 3.  Neurofibromatosis type 2.

Authors:  Ashok R Asthagiri; Dilys M Parry; John A Butman; H Jeffrey Kim; Ekaterini T Tsilou; Zhengping Zhuang; Russell R Lonser
Journal:  Lancet       Date:  2009-05-22       Impact factor: 79.321

4.  Yes-associated protein 1 is activated and functions as an oncogene in meningiomas.

Authors:  Gilson S Baia; Otavia L Caballero; Brent A Orr; Anita Lal; Janelle S Y Ho; Cynthia Cowdrey; Tarik Tihan; Christian Mawrin; Gregory J Riggins
Journal:  Mol Cancer Res       Date:  2012-05-22       Impact factor: 5.852

Review 5.  Advances in meningioma genetics: novel therapeutic opportunities.

Authors:  Matthias Preusser; Priscilla K Brastianos; Christian Mawrin
Journal:  Nat Rev Neurol       Date:  2018-01-05       Impact factor: 42.937

6.  Intracranial clear cell meningioma in two children with blood relations: two case reports and literature review.

Authors:  Zhiqi Li; Yi Zhang; Enming Wang; Zhiqiu Wang; Wengang Li; Shan Huang; Jun Li
Journal:  Childs Nerv Syst       Date:  2012-07-20       Impact factor: 1.475

7.  Association of Genetic Predisposition With Solitary Schwannoma or Meningioma in Children and Young Adults.

Authors:  Omar N Pathmanaban; Katherine V Sadler; Ian D Kamaly-Asl; Andrew T King; Scott A Rutherford; Charlotte Hammerbeck-Ward; Martin G McCabe; John-Paul Kilday; Christian Beetz; Nicola K Poplawski; D Gareth Evans; Miriam J Smith
Journal:  JAMA Neurol       Date:  2017-09-01       Impact factor: 18.302

Review 8.  Pediatric meningioma: current approaches and future direction.

Authors:  Rishi S Kotecha; Reimar C Junckerstorff; Sharon Lee; Catherine H Cole; Nicholas G Gottardo
Journal:  J Neurooncol       Date:  2011-01-04       Impact factor: 4.130

9.  Molecular and translational advances in meningiomas.

Authors:  Suganth Suppiah; Farshad Nassiri; Wenya Linda Bi; Ian F Dunn; Clemens Oliver Hanemann; Craig M Horbinski; Rintaro Hashizume; Charles David James; Christian Mawrin; Houtan Noushmehr; Arie Perry; Felix Sahm; Andrew Sloan; Andreas Von Deimling; Patrick Y Wen; Kenneth Aldape; Gelareh Zadeh
Journal:  Neuro Oncol       Date:  2019-01-14       Impact factor: 12.300

Review 10.  Pediatric microcystic meningioma: a clinical, histological, and radiographic case-based review.

Authors:  Jotham Manwaring; Amir Ahmadian; Stacie Stapleton; Ignacio Gonzalez-Gomez; Luis Rodriguez; Carolyn Carey; Gerald F Tuite
Journal:  Childs Nerv Syst       Date:  2012-12-19       Impact factor: 1.475

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.